Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 1218-0131	ICR Reference No: 201105-1218-016
Status: Historical Active	Previous ICR Reference No: 200806-1218-002
Agency/Subagency: DOL/OSHA	Agency Tracking No: 1218-0131(2011 SIPs III)
Title: Bloodborne Pathogens Standard (29 CFR 1910.1030)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 08/11/2011
Retrieve Notice of Action (NOA)	Date Received in OIRA: 05/27/2011
Terms of Clearance: Approved for a period of six months during which time DOL shall conduct notice and comment on the information requirements contained in this collection.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2012	36 Months From Approved	08/31/2011
Responses	877,905	0	878,238
Time Burden (Hours)	281,086	0	281,419
Cost Burden (Dollars)	35,978,301	0	32,978,301

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion	Change Due to Adjustment in Estimate
Annual Number of Responses	877,905	878,238	-333	0
Annual Time Burden (Hours)	281,086	281,419	-333	0
Annual Cost Burden (Dollars)	35,978,301	32,978,301	0	3,000,000

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The ICR assumed no burden hours and costs for employers to transfer employee exposure-monitoring and medical records to NIOSH or to notify NIOSH prior to disposal of such records; therefore, there are no program change reductions resulting from the SIPs III final. The adjustment increase is due to an increase in the number of establishments and the number of affected employees. The adjustment cost increase results form the increase in cost for employers to provide post exposure prophylaxis (PEP) to employees who have had occupational exposure to blood, and other body fluids, that may contain HIV.